Pay in 4 interest-free payments of $6.49 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
As of 2025, Retatrutide is in Phase 3 clinical trials
A novel dual amylin and calcitonin receptor agonist, KBP-089, induces weight loss through a reduction in fat, but not lean mass, while improving food preference
Product Facts Supplement Facts Serving Size 1 Vegan Tablet Servings Per Container 100 *Daily Value not established
Mexicos market is limited by out-of-pocket spend, but Novo Nordisks lower-dose semaglutide at 40% below U.S
US$ 29.49
US$ 26.02
US$ 27.57
US$ 29.10
US$ 24.76
US$ 20.15
